CareDx, Inc. (CDNA)

Slide locked Sign in to view

Slide schematic 7/9

callout 0/1 paragraph 6/6 quote 0/1 source-note 1/1

2 without position callout 1 · quote 1

calloutquote

Components 9

callout paragraph paragraph paragraph paragraph paragraph paragraph quote source-note

Tools 1

Narrative foundations (from the Storymakers methodology) slide · 50%

The company immediately began enrollment on a massive 1000-patient clinical trial, which it expected to “include approximately 10,000 reimbursed AlloSure tests over the next 3 years, thus representin

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

The slide argues that CareDx effectively monetized the research process itself, creating a conflict of interest and a circular revenue model.